Philip Bedford Consulting Limited is a Cambridge-based consultancy specialising in clinical development and regulatory affairs services for companies developing biological pharmaceutical products and small molecules targeted for licensure in Europe and the United States of America. Services include:
Philip Bedford Consulting offers a unique blend of scientific knowledge with hands-on experience covering most aspects of the biopharmaceutical development process. The Company prides itself on providing a high-quality service in a flexible but timely manner.
With more than 30 years of experience in both “blue chip” pharmaceutical and small cutting-edge biopharmaceutical
companies, Philip Bedford has overseen the submission of 2 Biologics Licence Applications, 8 Investigational New Drug
Applications and several EU Clinical Trial Applications.
In addition, he has managed more than 100 clinical trials from Phase 1 to 4. Scientific expertise includes, but is not limited
to, vaccines, cell-based therapies, monoclonal antibodies and biological responses modifiers used in cancer, infectious disease,
autoimmune disease, transplant rejection and wound care.
Read full profile >>